AlphaVest Acquisition (ATMV) 10-Q 11 Aug 23 2023 Q2 Quarterly report Financial data

Cover

Cover - shares	6 Months Ended
	Jun. 30, 2023	Aug. 11, 2023
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Jun. 30, 2023
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2023
Current Fiscal Year End Date	--12-31
Entity File Number	001-41574
Entity Registrant Name	ALPHAVEST ACQUISITION CORP
Entity Central Index Key	0001937891
Entity Incorporation, State or Country Code	E9
Entity Address, Address Line One	420 Lexington Ave
Entity Address, Address Line Two	Suite 2446
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10170
City Area Code	203
Local Phone Number	998-5540
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false
Entity Shell Company	true
Entity Common Stock, Shares Outstanding		9,180,500
Units, each consisting of one share of common stock and one right
Title of 12(b) Security	Units, each consisting of one share of common stock and one right
Trading Symbol	ATMVU
Security Exchange Name	NASDAQ
Common stock, par value $0.0001 per share
Title of 12(b) Security	Common stock, par value $0.0001 per share
Trading Symbol	ATMV
Security Exchange Name	NASDAQ
Rights, each right entitling the holder thereof to one-tenth of one share of common stock
Title of 12(b) Security	Rights, each right entitling the holder thereof to one-tenth of one share of common stock
Trading Symbol	ATMVR
Security Exchange Name	NASDAQ

Balance Sheets

Balance Sheets - USD ($)	Jun. 30, 2023	Dec. 31, 2022
Current assets:
Cash	$ 220,799	$ 659,035
Prepaid expenses	34,190	82,771
Total current assets	254,989	741,806
Prepaid expenses – Non-current	32,380	32,380
Marketable securities held in trust account	72,055,901	70,418,228
Total Assets	72,343,270	71,192,414
Current Liabilities:
Accounts Payable and accrued offering costs and expenses	49,436	248,034
Due to related party	9,837	9,837
Total Current Liabilities	59,273	257,871
Commitments and contingencies
Common stock subject to possible redemption (6,900,000 shares at $10.44 and $10.20 per share as of June 30, 2023 and December 31, 2022)	72,055,901	70,380,000
Shareholders’ Equity:
Preferred stock, $0.0001 par value; 2,000,000 shares authorized; none issued and outstanding
Ordinary shares, $0.0001 par value; 200,000,000 shares authorized; 2,280,500 shares issued and outstanding	228	228
Additional paid-in capital		596,893
Retained earnings (Accumulated deficit)	227,868	(42,578)
Total Shareholders’ Equity	228,096	554,543
Total Liabilities, Redeemable Common Stock, and Shareholders’ Equity	$ 72,343,270	$ 71,192,414

Balance Sheets (Parenthetical)

Balance Sheets (Parenthetical) - $ / shares	Jun. 30, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Temproary equity, redemption shares	6,900,000	6,900,000
Temproary equity, redemption price per share	$ 10.44	$ 10.20
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	2,000,000	2,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	200,000,000	200,000,000
Common stock, shares issued	2,280,500	2,280,500
Common stock, shares outstanding	2,280,500	2,280,500

Statements of Operations (Unaud

Statements of Operations (Unaudited) - USD ($)		3 Months Ended		6 Months Ended
		Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Formation and operating costs		$ 130,187		$ 288,373	$ 3,749
Loss from operations		(130,187)		(288,373)	(3,749)
Other Income:
Interest income on investments held in trust account		834,681		1,637,673
Bank interest income		61		154
Total other income		834,743		1,637,827
Net income (loss)		$ 704,556		$ 1,349,454	$ (3,749)
Redeemable Common Stock [Member]
Other Income:
Weighted average common stock outstanding, common stock, non-redeemable		2,576,817		2,576,817
Basic net loss per share, common stock, non-redeemable		$ 0.30		$ 0.58
Diluted net loss per share, common stock, non-redeemable		$ 0.30		$ 0.58
Nonredeemable Common Stock [Member]
Other Income:
Weighted average common stock outstanding, common stock, non-redeemable	[1]	2,010,986	1,500,000	2,010,986	1,500,000
Basic net loss per share, common stock, non-redeemable		$ (0.03)		$ (0.07)	$ (0.002)
Diluted net loss per share, common stock, non-redeemable		$ (0.03)		$ (0.07)	$ (0.002)
[1]Excluded an aggregate of 225,000

Statements of Operations (Una_2

Statements of Operations (Unaudited) (Parenthetical)	6 Months Ended
	Jun. 30, 2022 shares
Income Statement [Abstract]
Shares subject to forfeiture to underwriters	225,000

Statement of Changes in Shareho

Statement of Changes in Shareholders' Equity (Unaudited) - USD ($)		Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance at Jan. 13, 2022
Balance, shares at Jan. 13, 2022
Net income (loss)				(3,749)	(3,749)
Common stock issued to Sponsor	[1]	$ 173	24,827		25,000
Common stock issued to sponsor, shares	[1]	1,725,000
Balance at Mar. 31, 2022		$ 173	24,827	(3,749)	21,251
Balance, shares at Mar. 31, 2022		1,725,000
Balance at Jan. 13, 2022
Balance, shares at Jan. 13, 2022
Net income (loss)					(3,749)
Balance at Jun. 30, 2022		$ 173	24,827	(3,749)	21,251
Balance, shares at Jun. 30, 2022		1,725,000
Balance at Mar. 31, 2022		$ 173	24,827	(3,749)	21,251
Balance, shares at Mar. 31, 2022		1,725,000
Net income (loss)
Balance at Jun. 30, 2022		$ 173	24,827	(3,749)	21,251
Balance, shares at Jun. 30, 2022		1,725,000
Balance at Dec. 31, 2022		$ 228	596,893	(42,578)	554,543
Balance, shares at Dec. 31, 2022		2,280,500
Accretion for common stock subject to redemption amount			(596,893)	(244,326)	(841,220)
Net income (loss)				644,898	644,898
Balance at Mar. 31, 2023		$ 228		357,993	358,221
Balance, shares at Mar. 31, 2023		2,280,500
Balance at Dec. 31, 2022		$ 228	596,893	(42,578)	554,543
Balance, shares at Dec. 31, 2022		2,280,500
Net income (loss)					1,349,454
Balance at Jun. 30, 2023		$ 228		227,868	228,096
Balance, shares at Jun. 30, 2023		2,280,500
Balance at Mar. 31, 2023		$ 228		357,993	358,221
Balance, shares at Mar. 31, 2023		2,280,500
Accretion for common stock subject to redemption amount				(834,681)	(834,681)
Net income (loss)				704,556	704,556
Balance at Jun. 30, 2023		$ 228		$ 227,868	$ 228,096
Balance, shares at Jun. 30, 2023		2,280,500
[1]Included an aggregate of 225,000

Statement of Changes in Share_2

Statement of Changes in Shareholders' Equity (Unaudited) (Parenthetical)	6 Months Ended
	Jun. 30, 2022 shares
Statement of Stockholders' Equity [Abstract]
Shares subject to forfeiture to underwriters	225,000

Statement of Cash Flows (Unaudi

Statement of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Cash flows from operating activities:
Net income (loss)	$ 1,349,454	$ (3,749)
Adjustments to reconcile net loss to net cash provided by operating activities:
Prepaid expense	48,582
Deferred offering costs		(220,695)
Accounts payable and accrued offering costs and expenses	(198,599)	66,695
Due to related party		157,749
Trust investment income	(1,637,673)
Net cash used in operating activities	(438,236)
Net change in cash	(438,236)
Cash at beginning of period	659,035
Cash at end of period	220,799
Supplemental disclosure of noncash investing and financing activities
Accretion for common stock subject to redemption amount	1,675,901
Deferred offering costs paid by Sponsor in exchange for issuance of common stock		$ 25,000

DESCRIPTION OF ORGANIZATION AND

DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN	6 Months Ended
	Jun. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN	NOTE 1 — DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN AlphaVest Acquisition Corp (the “Company”) was incorporated in the Cayman Islands on January 14, 2022. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses (the “Business Combination”). The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. As of June 30, 2023, the Company had not commenced any operations. All activity for the period from January 14, 2022 (inception) through June 30, 2023 relates to the Company’s formation and the initial public offering (“Initial Public Offering”), which is described below, and subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion an initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. The registration statement for the Company’s Initial Public Offering (the “Registration Statement”) was declared effective on December 19, 2022. On December 22, 2022, the Company consummated the Initial Public Offering of 6,000,000 60,000,000 390,000 10.00 Following the closing of the Initial Public Offering on December 22, 2022, an amount of $ 61,200,000 10.20 On December 29, 2022, our Underwriter fully exercised their over-allotment option, resulting in an additional 900,000 9,000,000 40,500 10.00 405,000 As of June 30, 2023, transaction costs related to the issuances described above amounted to $ 3,734,629 1,725,000 629,929 1,425,000 The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The stock exchange listing rules require that the Business Combination must be with one or more operating businesses or assets with a fair market value equal to at least 80 50 10.20 The Company will provide the holders of the outstanding Public Shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their Public Shares either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer in connection with the Business Combination. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $ 10.20 All of the Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, if there is a shareholder vote or tender offer in connection with the Company’s Business Combination and in connection with certain amendments to the Company’s amended and restated certificate of incorporation (the “Certificate of Incorporation”). In accordance with the rules of the U.S. Securities and Exchange Commission (the “SEC”) and its guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99, redemption provisions not solely within the control of a company require common stock subject to redemption to be classified outside of permanent equity. Given that the Public Shares will be issued with other freestanding instruments (i.e., rights), the initial carrying value of common stock classified as temporary equity will be the allocated proceeds determined in accordance with ASC 470-20. The common stock is subject to ASC 480-10-S99. If it is probable that the equity instrument will become redeemable, the Company has the option to either (i) accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or (ii) recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company has elected the immediate fair value recognition method. The accretion will be treated as a deemed dividend (i.e., a reduction to retained earnings, or in absence of retained earnings, additional paid-in capital). While redemptions cannot cause the Company’s net tangible assets to fall below $ 5,000,001 The Company will not redeem Public Shares in an amount that would cause its net tangible assets to be less than $ 5,000,001 Notwithstanding the foregoing, if the Company seeks shareholder approval of the Business Combination and the Company does not conduct redemptions pursuant to the tender offer rules, a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public Shares without the Company’s prior written consent. The Sponsor has agreed (a) to waive its redemption rights with respect to any Founder Shares and Public Shares held by it in connection with the completion of a Business Combination and (b) not to propose an amendment to the Amended and Restated Memorandum and Articles of Association (i) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the Company’s initial Business Combination or to redeem 100 The Company will have until 12 months (or 18 months if the Company extends the period) from the closing of the Initial Public Offering to consummate a Business Combination (the “Combination Period”). However, if the Company has not completed a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem 100% of the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned and not previously released to us to pay our taxes, if any (less up to $ 100,000 The Sponsor has agreed to waive its rights to liquidating distributions from the Trust Account with respect to the Founder Shares it will receive if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor or any of its respective affiliates acquire Public Shares, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Proposed Public Offering price per Unit ($ 10.00 In order to protect the amounts held in the Trust Account, the Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party (other than the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below the lesser of (1) $ 10.20 10.00 Liquidity and Management’s Plan In connection with the Company’s assessment of going concern considerations in accordance with Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	6 Months Ended
	Jun. 30, 2023
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying financial statement has been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”). Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of the financial statement in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. At June 30, 2023 and December 31, 2022, the Company had a cash balance of $ 220,799 659,035 Marketable securities Held in Trust Account At June 30, 2023 and December 31, 2022, substantially all of the assets held in the Trust Account were held in money market funds which are invested only in U.S. government securities with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations. All of the Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in interest income on investments held in trust account in the accompanying statement of operations. Except with respect to interest earned on the funds held in the trust account that may be released to us to pay our tax obligations, unless and until the Company complete our initial business combination, no proceeds held in the trust account will be available for our use, and interest income on investments will be reinvested in U.S. government securities. Income earned on these investments will be fully reinvested into the investments held in Trust Account and therefore considered as an adjustment to reconcile net income (loss) to net cash used in operating activities in the statements of cash flows. Such income reinvested will be used to redeem all or a portion of the ordinary shares upon the completion of business combination. At June 30, 2023, the Company had $ 72,055,901 834,681 Offering Costs associated with a Public Offering The Company complies with the requirements of FASB ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A — “ Expenses of Offering.” 3,734,630 Common Stock Subject to Possible Redemption The Company accounts for its common stock subject to possible redemption in accordance with the guidance enumerated in ASC 480 “ Distinguishing Liabilities from Equity 72,055,901 70,380,000 At June 30, 2023 and December 31, 2022, the common stock reflected in the balance sheets are reconciled in the following table: SCHEDULE OF INITIAL PUBLIC OFFERING PROCEEDS TO COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION Initial Public Offering, including over-allotment $ 69,000,000 Private Placement 4,305,000 Total 73,305,000 Cash to the operating account 657,285 Underwriting expenses 1,725,000 Other offering expenses 263,675 Amount held back for Sponsor portion of risk capital in event of full exercise of the over-allotment 279,040 Total 2,925,000 Balance, December 31, 2022 $ 70,380,000 Accretion for common stock subject to redemption amount 841,220 Balance, March 31, 2023 $ 71,221,220 Accretion for common stock subject to redemption amount 834,681 Balance, June 30, 2023 $ 72,055,901 Income Taxes The Company follows the asset and liability method of accounting for income taxes under ASC 740, “ Income Taxes ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no no There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statement. Recent Accounting Standards In August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020-06, “ Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”) Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

INITIAL PUBLIC OFFERING

INITIAL PUBLIC OFFERING	6 Months Ended
	Jun. 30, 2023
Initial Public Offering
INITIAL PUBLIC OFFERING	NOTE 3. INITIAL PUBLIC OFFERING Pursuant to the Initial Public Offering, the Company sold 6,000,000 10.00 Each Unit consists of one share of common stock and one right to receive one-tenth (1/10) of one Common Stock upon the consummation of the Company’s initial business combination one right (“Public Right”). 900,000 9,000,000

PRIVATE PLACEMENT

PRIVATE PLACEMENT	6 Months Ended
	Jun. 30, 2023
Private Placement
PRIVATE PLACEMENT	NOTE 4. PRIVATE PLACEMENT 390,000 Each Unit consists of one share of common stock and one right to receive one-tenth (1/10) of one share of Common Stock upon the consummation of the Company’s initial business combination (“Private Right”). In connection with the underwriter’s full exercise of their over-allotment option, the Company also consummated the sale of an additional 40,500 10.00 405,000

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	6 Months Ended
	Jun. 30, 2023
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 5. RELATED PARTY TRANSACTIONS Founder Shares On February 7, 2022, the sponsor received 1,725,000 25,000 225,000 On April 18, 2023, AlphaVest Holding LP, one of our sponsors, transferred an aggregate of 1,035,000 The Sponsors have agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of: (A) six months after the completion of the initial Business Combination and (B) the date on which we complete a liquidation, merger, share exchange, reorganization or other similar transaction after our initial business combination that results in all of our public shareholders having the right to exchange their common stock for cash, securities or other property. Administrative Services Agreement Commencing on the date the Units are first listed on the Nasdaq, the Company has agreed to pay TenX Global Capital LP a total of $ 10,000 30,000 Promissory Note — Related Party On June 3, 2022, the Company issued an unsecured promissory note to the Sponsor (the “Promissory Note”), pursuant to which the Company could borrow up to an aggregate of $ 150,000 Website Service On February 22, 2023 the Company has agreed to pay TenX Global Capital LP a total of $ 784 943

COMMITMENTS & CONTINGENCIES

COMMITMENTS & CONTINGENCIES	6 Months Ended
	Jun. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS & CONTINGENCIES	NOTE 6. COMMITMENTS & CONTINGENCIES Registration Rights The holders of the Founder Shares, common stock issued to EBC, Private Placement Units and Units that may be issued upon conversion of Working Capital Loans (and all underlying securities) will be entitled to registration rights pursuant to a registration rights agreement signed prior to or on the effective date of Proposed Public Offering requiring the Company to register such securities for resale. The holders of these securities will be entitled to make up to three demands, excluding short form registration demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not be required to effect or permit any registration or cause any registration statement to become effective until the securities covered thereby are released from their lock-up restrictions. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The Company and EBC signed an engagement letter which was amended on September 15, 2022, pursuant to which, the Company will grant the underwriters a 45-day option from the date of Proposed Public Offering to purchase up to 900,000 The underwriters are entitled to a cash underwriting discount of $ 0.25 1,725,000 Business Combination Marketing Agreement The Company has engaged EBC as an advisor in connection with its Business Combination to assist in holding meetings with the Company stockholders to discuss the potential Business Combination and the target business’ attributes, introduce the Company to potential investors that are interested in purchasing its securities in connection with its initial Business Combination and assist with press releases and public filings in connection with the Business Combination. The Company will pay EBC a cash fee for such services upon the consummation of its initial business combination in an amount equal to 3.5 2,415,000

STOCKHOLDERS_ EQUITY

STOCKHOLDERS’ EQUITY	6 Months Ended
	Jun. 30, 2023
Equity [Abstract]
STOCKHOLDERS’ EQUITY	NOTE 7. STOCKHOLDERS’ EQUITY Preferred Stock 2,000,000 0.0001 no Common Stock 200,000,000 0.0001 On February 7, 2022, the Sponsor received 1,725,000 25,000 1,725,000 225,000 20 On July 11, 2022, EBC received an aggregate of 125,000 1,750 0.014 1,812 On December 22, 2022, the Sponsor and EBC received an aggregate of 390,000 365,000 25,000 10.00 3,900,000 On December 29, 2022, as a result of the underwriters’ election to fully exercise their over-allotment option, the Sponsor and EBC received additional 40,500 37,904 2,596 10.00 As of June 30, 2023, there were 2,280,500 6,900,000 Rights —

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS	6 Months Ended
	Jun. 30, 2023
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENTS	NOTE 8. FAIR VALUE MEASUREMENTS The Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. The Company classifies its securities in the Trust Account that are invested in funds, such as Mutual Funds or Money Market Funds, that primarily invest in U.S. Treasury and equivalent securities as Trading Securities in accordance with ASC Topic 320 “Investments - Debt and Equity Securities. Trading Securities are recorded at fair market value on the accompanying balance sheet. At June 30, 2023, assets held in the Trust Account were comprised of $ 72,055,901 The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at June 30, 2023 and December 31, 2022 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: SCHEDULE OF ASSETS MEASURED AT FAIR VALUE ON A RECURRING BASIS Trading Securities Level Fair Value June 30, 2023 Marketable securities held in the Trust Account 1 $ 72,055,901 December 31, 2022 Marketable securities held in the Trust Account 1 $ 70,418,228

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	6 Months Ended
	Jun. 30, 2023
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 9. SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	6 Months Ended
	Jun. 30, 2023
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying financial statement has been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”).
Emerging Growth Company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates	Use of Estimates The preparation of the financial statement in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. At June 30, 2023 and December 31, 2022, the Company had a cash balance of $ 220,799 659,035
Marketable securities Held in Trust Account	Marketable securities Held in Trust Account At June 30, 2023 and December 31, 2022, substantially all of the assets held in the Trust Account were held in money market funds which are invested only in U.S. government securities with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations. All of the Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in interest income on investments held in trust account in the accompanying statement of operations. Except with respect to interest earned on the funds held in the trust account that may be released to us to pay our tax obligations, unless and until the Company complete our initial business combination, no proceeds held in the trust account will be available for our use, and interest income on investments will be reinvested in U.S. government securities. Income earned on these investments will be fully reinvested into the investments held in Trust Account and therefore considered as an adjustment to reconcile net income (loss) to net cash used in operating activities in the statements of cash flows. Such income reinvested will be used to redeem all or a portion of the ordinary shares upon the completion of business combination. At June 30, 2023, the Company had $ 72,055,901 834,681
Offering Costs associated with a Public Offering	Offering Costs associated with a Public Offering The Company complies with the requirements of FASB ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A — “ Expenses of Offering.” 3,734,630
Common Stock Subject to Possible Redemption	Common Stock Subject to Possible Redemption The Company accounts for its common stock subject to possible redemption in accordance with the guidance enumerated in ASC 480 “ Distinguishing Liabilities from Equity 72,055,901 70,380,000 At June 30, 2023 and December 31, 2022, the common stock reflected in the balance sheets are reconciled in the following table: SCHEDULE OF INITIAL PUBLIC OFFERING PROCEEDS TO COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION Initial Public Offering, including over-allotment $ 69,000,000 Private Placement 4,305,000 Total 73,305,000 Cash to the operating account 657,285 Underwriting expenses 1,725,000 Other offering expenses 263,675 Amount held back for Sponsor portion of risk capital in event of full exercise of the over-allotment 279,040 Total 2,925,000 Balance, December 31, 2022 $ 70,380,000 Accretion for common stock subject to redemption amount 841,220 Balance, March 31, 2023 $ 71,221,220 Accretion for common stock subject to redemption amount 834,681 Balance, June 30, 2023 $ 72,055,901
Income Taxes	Income Taxes The Company follows the asset and liability method of accounting for income taxes under ASC 740, “ Income Taxes ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no no There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statement.
Recent Accounting Standards	Recent Accounting Standards In August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020-06, “ Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”) Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	6 Months Ended
	Jun. 30, 2023
Accounting Policies [Abstract]
SCHEDULE OF INITIAL PUBLIC OFFERING PROCEEDS TO COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION	At June 30, 2023 and December 31, 2022, the common stock reflected in the balance sheets are reconciled in the following table: SCHEDULE OF INITIAL PUBLIC OFFERING PROCEEDS TO COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION Initial Public Offering, including over-allotment $ 69,000,000 Private Placement 4,305,000 Total 73,305,000 Cash to the operating account 657,285 Underwriting expenses 1,725,000 Other offering expenses 263,675 Amount held back for Sponsor portion of risk capital in event of full exercise of the over-allotment 279,040 Total 2,925,000 Balance, December 31, 2022 $ 70,380,000 Accretion for common stock subject to redemption amount 841,220 Balance, March 31, 2023 $ 71,221,220 Accretion for common stock subject to redemption amount 834,681 Balance, June 30, 2023 $ 72,055,901

FAIR VALUE MEASUREMENTS (Tables

FAIR VALUE MEASUREMENTS (Tables)	6 Months Ended
	Jun. 30, 2023
Fair Value Disclosures [Abstract]
SCHEDULE OF ASSETS MEASURED AT FAIR VALUE ON A RECURRING BASIS	The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at June 30, 2023 and December 31, 2022 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: SCHEDULE OF ASSETS MEASURED AT FAIR VALUE ON A RECURRING BASIS Trading Securities Level Fair Value June 30, 2023 Marketable securities held in the Trust Account 1 $ 72,055,901 December 31, 2022 Marketable securities held in the Trust Account 1 $ 70,418,228

DESCRIPTION OF ORGANIZATION A_2

DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN (Details Narrative) - USD ($)				6 Months Ended
	Dec. 29, 2022	Dec. 29, 2022	Dec. 22, 2022	Jun. 30, 2023
Subsidiary, Sale of Stock [Line Items]
Investment of cash in trust account			$ 61,200,000
Cash deposited in trust account per unit			$ 10.20
Transaction cost				$ 3,734,629
Underwriting expenses				1,725,000
Offering costs				629,929
Assets held in trust				$ 1,425,000
Condition for future business combination use of proceeds percentage				80%
Condition for future business combination threshold percentage ownership				50%
Minimum net worth to consummate business combination				$ 5,000,001
Percentage of public shares that would not be redeemed if business combination is not completed within combination period				100%
Expenses payable on dissolution				$ 100,000
Value per share to be maintained in the trust account				$ 10.20
Maximum [Member]
Subsidiary, Sale of Stock [Line Items]
Value per share to be maintained in the trust account				$ 10
IPO [Member]
Subsidiary, Sale of Stock [Line Items]
Issuance of common stock, shares			6,000,000	6,000,000
Proceeds from sale of units			$ 60,000,000
Sale of stock, price per share			$ 10.20	$ 10.20
Private Placement [Member]
Subsidiary, Sale of Stock [Line Items]
Number of private units sold, shares			390,000	390,000
Sale of stock, price per share				$ 10
Number of private units issued, price per share			$ 10
Private Placement [Member] | Sponsor [Member]
Subsidiary, Sale of Stock [Line Items]
Number of private units sold, shares			390,000
Sale of stock, price per share			$ 10
Over-Allotment Option [Member]
Subsidiary, Sale of Stock [Line Items]
Issuance of common stock, shares		900,000
Number of private units sold, shares	40,500
Sale of stock, price per share				$ 10
Units issued during the period shares	900,000
Units issued aggregate amount	$ 9,000,000
Number of additional private units issued	40,500	40,500
Number of private units issued, price per share	$ 10	$ 10
Proceeds from issuance of private units	$ 405,000

SCHEDULE OF INITIAL PUBLIC OFFE

SCHEDULE OF INITIAL PUBLIC OFFERING PROCEEDS TO COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2023
Subsidiary, Sale of Stock [Line Items]
Total			$ 73,305,000
Cash to the operating account			657,285
Underwriting expenses			1,725,000
Other offering expenses			263,675
Amount held back for Sponsor portion of risk capital in event of full exercise of the over-allotment			279,040
Total			2,925,000
Balance	$ 71,221,220	$ 70,380,000	70,380,000
Accretion for common stock subject to redemption amount	834,681	841,220
Balance	$ 72,055,901	$ 71,221,220	72,055,901
I P O Including Over Allotment [Member]
Subsidiary, Sale of Stock [Line Items]
Total			69,000,000
Private Placement [Member]
Subsidiary, Sale of Stock [Line Items]
Total			$ 4,305,000

SUMMARY OF SIGNIFICANT ACCOUN_4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
Financial Instruments Subject to Mandatory Redemption by Settlement Terms [Line Items]
Cash	$ 220,799		$ 220,799		$ 659,035
Investments held in trust account	72,055,901		72,055,901		70,418,228
Investment income interest	834,681		1,637,673
Offering costs	3,734,630		3,734,630
Unrecognized tax benefits	0		0		0
Accrued for interest and penalties	0		0		0
Common Stock Subject to Mandatory Redemption [Member]
Financial Instruments Subject to Mandatory Redemption by Settlement Terms [Line Items]
Common stock subject to possible redemption value	$ 72,055,901		$ 72,055,901		$ 70,380,000

INITIAL PUBLIC OFFERING (Detail

INITIAL PUBLIC OFFERING (Details Narrative) - USD ($)				3 Months Ended	6 Months Ended
		Dec. 29, 2022	Dec. 22, 2022	Mar. 31, 2022	Jun. 30, 2023
Subsidiary, Sale of Stock [Line Items]
Number of shares issued, value	[1]			$ 25,000
IPO [Member]
Subsidiary, Sale of Stock [Line Items]
Number of shares issued			6,000,000		6,000,000
Sale of stock, price per share			$ 10.20		$ 10.20
Sale of stock, description of transaction					Each Unit consists of one share of common stock and one right to receive one-tenth (1/10) of one Common Stock upon the consummation of the Company’s initial business combination one right (“Public Right”).
Over-Allotment Option [Member]
Subsidiary, Sale of Stock [Line Items]
Number of shares issued		900,000
Sale of stock, price per share					$ 10
Number of shares issued, value		$ 9,000,000
[1]Included an aggregate of 225,000

PRIVATE PLACEMENT (Details Narr

PRIVATE PLACEMENT (Details Narrative) - USD ($)			6 Months Ended
	Dec. 29, 2022	Dec. 22, 2022	Jun. 30, 2023
Private Placement [Member]
Subsidiary, Sale of Stock [Line Items]
Sale of stock, number of shares issued		390,000	390,000
Sale of stock, description			Each Unit consists of one share of common stock and one right to receive one-tenth (1/10) of one share of Common Stock upon the consummation of the Company’s initial business combination (“Private Right”).
Number of private units issued, price per share		$ 10
Over-Allotment Option [Member]
Subsidiary, Sale of Stock [Line Items]
Sale of stock, number of shares issued	40,500
Number of additional private units issued	40,500
Number of private units issued, price per share	$ 10
Proceeds from issuance of private units	$ 405,000

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)					3 Months Ended		6 Months Ended
	Feb. 22, 2023	Dec. 29, 2022	Jun. 03, 2022	Feb. 07, 2022	Jun. 30, 2023	Jun. 30, 2023	Jun. 30, 2023	Jun. 30, 2022	Apr. 18, 2023
Related Party Transaction [Line Items]
Deferred offering costs					$ 629,929	$ 629,929	$ 629,929
Shares subject to forfeiture to underwriters								225,000
Fees for services						$ 30,000
Unsecured promissory note			$ 150,000
Annual website service fees	$ 784				$ 943
Alpha Vest Holding L P [Member] | Peace Capital Limited [Member]
Related Party Transaction [Line Items]
Transferred shares									1,035,000
Over-Allotment Option [Member]
Related Party Transaction [Line Items]
Sale of stock, number of shares issued		40,500
Founder Shares [Member]
Related Party Transaction [Line Items]
Deferred offering costs				$ 25,000
Founder Shares [Member] | Over-Allotment Option [Member]
Related Party Transaction [Line Items]
Shares subject to forfeiture to underwriters				225,000
TenX Global Capital LP [Member]
Related Party Transaction [Line Items]
Selling general and administrative expense							$ 10,000
Common Stock [Member] | Over-Allotment Option [Member]
Related Party Transaction [Line Items]
Shares subject to forfeiture to underwriters				225,000
Common Stock [Member] | Founder Shares [Member]
Related Party Transaction [Line Items]
Sale of stock, number of shares issued				1,725,000

COMMITMENTS & CONTINGENCIES (De

COMMITMENTS & CONTINGENCIES (Details Narrative) - USD ($)			6 Months Ended
	Dec. 22, 2022	Sep. 15, 2022	Jun. 30, 2023
Subsidiary, Sale of Stock [Line Items]
Cash underwriting discount per unit			$ 0.25
Aggregate cash underwriting discount			$ 1,725,000
Sponsor [Member]
Subsidiary, Sale of Stock [Line Items]
Proceeds from initial public offering			$ 2,415,000
Over-Allotment Option [Member]
Subsidiary, Sale of Stock [Line Items]
Additional units to cover over-allotments		900,000
IPO [Member]
Subsidiary, Sale of Stock [Line Items]
Percentage of cash fee upon initial business combination on gross proceeds			3.50%
Proceeds from initial public offering	$ 60,000,000

STOCKHOLDERS_ EQUITY (Details N

STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)					6 Months Ended
	Dec. 29, 2022	Dec. 22, 2022	Jul. 11, 2022	Feb. 07, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock, shares authorized					2,000,000		2,000,000
Preferred stock par or stated value per share					$ 0.0001		$ 0.0001
Preferred stock, shares issued					0		0
Preferred stock, shares outstanding					0		0
Common stock shares authorized					200,000,000		200,000,000
Common stock par or stated value per share					$ 0.0001		$ 0.0001
Deferred offering costs					$ 629,929
Shares subject to forfeiture to underwriters						225,000
Common stock, issued					2,280,500		2,280,500
Common stock, outstanding					2,280,500		2,280,500
Temproary equity, redemption shares					6,900,000		6,900,000
Over-Allotment Option [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Sale of stock, number of shares issued	40,500
Number of shares issued, price per share	$ 10
Private Placement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Sale of stock, number of shares issued		390,000			390,000
Number of shares issued, price per share		$ 10
Proceeds from issuance of private placement		$ 3,900,000
Founder Shares [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Deferred offering costs				$ 25,000
Founder Shares [Member] | Over-Allotment Option [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Shares subject to forfeiture to underwriters				225,000
EBC Founder Shares [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued, price per share			$ 0.014
Estimated fair value			$ 1,812
EBC Founder Shares [Member] | Over-Allotment Option [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Sale of stock, number of shares issued	2,596
EBC Founder Shares [Member] | Private Placement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Sale of stock, number of shares issued		25,000
Sponsor [Member] | Over-Allotment Option [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Sale of stock, number of shares issued	37,904
Sponsor [Member] | Private Placement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Sale of stock, number of shares issued		365,000
Common Stock [Member] | Over-Allotment Option [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Shares subject to forfeiture to underwriters				225,000
Common Stock [Member] | Founder Shares [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Sale of stock, number of shares issued				1,725,000
Percentage of common stock issued and outstanding				20%
Common Stock [Member] | EBC Founder Shares [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Sale of stock, number of shares issued			125,000
Aggregate purchase price			$ 1,750

SCHEDULE OF ASSETS MEASURED AT

SCHEDULE OF ASSETS MEASURED AT FAIR VALUE ON A RECURRING BASIS (Details) - USD ($)	Jun. 30, 2023	Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities held in the Trust Account	$ 72,055,901	$ 70,418,228
Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities held in the Trust Account	$ 72,055,901	$ 70,418,228

FAIR VALUE MEASUREMENTS (Detail

FAIR VALUE MEASUREMENTS (Details Narrative) - USD ($)	Jun. 30, 2023	Dec. 31, 2022
Cash and Cash Equivalents [Line Items]
Marketable securities held in trust account	$ 72,055,901	$ 70,418,228
US Treasury Securities [Member]
Cash and Cash Equivalents [Line Items]
Marketable securities held in trust account	$ 72,055,901